Is Sensus Healthcare, Inc. (SRTS) Halal?

NASDAQ Healthcare United States $65M
✗ NOT HALAL
Confidence: 83/100
Sensus Healthcare, Inc. (SRTS) is Not Halal under AAOIFI Standard 21. While the debt ratio of 0.9% is acceptable, the cash and interest-bearing securities ratio of 31.5% exceeds the 30% threshold. Sensus Healthcare, Inc. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 0.9%
/ 30%
31.5%
/ 30%
28.2%
/ 30%
N/A ✗ NOT HALAL
DJIM 0.9%
/ 33%
31.5%
/ 33%
28.2%
/ 33%
N/A ✓ HALAL
MSCI 1.0%
/ 33%
35.5%
/ 33%
31.7%
/ 33%
N/A ✗ NOT HALAL
S&P 0.9%
/ 33%
31.5%
/ 33%
28.2%
/ 33%
N/A ✓ HALAL
FTSE 1.0%
/ 33%
35.5%
/ 33%
31.7%
/ 50%
N/A ✗ NOT HALAL

Financial Highlights

EPS
$-0.47
P/B Ratio
2.5
EV/EBITDA
-5.1
EV: $51M
Revenue
$27M
Growth: 155.7%
Beta
1.3
High volatility
Current Ratio
9.7

Profitability

Gross Margin 43.2%
Operating Margin 40.8%
Net Margin -28.1%
Return on Equity (ROE) -14.9%
Return on Assets (ROA) -11.2%

Cash Flow & Balance Sheet

Operating Cash Flow$528,000
Free Cash Flow$332,000
Total Debt$471,000
Debt-to-Equity0.9
Current Ratio9.7
Total Assets$53M

Price & Trading

Last Close$4.01
50-Day MA$4.43
200-Day MA$4.07
Avg Volume98K
Beta1.3
52-Week Range
$3.03
$5.92

About Sensus Healthcare, Inc. (SRTS)

CEO
Mr. Joseph C. Sardano
Employees
60
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NASDAQ
Market Cap
$65M
Currency
USD

Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 +; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos, as well as provide operational healthcare services for dermatology clinics. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. The company was incorporated in 2010 and is based in Boca Raton, Florida.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is Sensus Healthcare, Inc. (SRTS) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), Sensus Healthcare, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is Sensus Healthcare, Inc.'s debt ratio?

Sensus Healthcare, Inc.'s debt ratio is 0.9% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 1.0%.

What are Sensus Healthcare, Inc.'s key financial metrics?

Sensus Healthcare, Inc. has a market capitalization of $65M, and revenue of $27M. The company maintains a gross margin of 43.2% and a net margin of -28.1%. Return on equity stands at -14.9%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.